P53 and Endoglin, Two Biomarkers for Predicting HBV and Hepatocellular Carcinoma in Egyptian Patients
Journal of advanced Biomedical and Pharmaceutical Sciences
doi 10.21608/jabps.2020.24533.1075
Full Text
Open PDFAbstract
Available in full text
Date
March 25, 2020
Authors
Publisher
Egypts Presidential Specialized Council for Education and Scientific Research